Why Synthorx Stock Is Soaring Today

Shares of the clinical-stage biotech Synthorx (NASDAQ: THOR) jumped by an eye-popping 169% right out of the gate Monday morning. What's behind this enormous spike?

Synthorx's stock is on fire today in response to an all-cash buyout agreement with French pharma giant Sanofi (NASDAQ: SNY) for $68 per share. On a fully diluted basis, the total equity value of this buyout works out to a hefty $2.5 billion.  

Image source: Getty Images.

Continue reading

Source Fool.com